Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting

Jenna E. Yousif; Joseph F. Merola; Lourdes M. Perez-Chada; Caterina Zagona-Prizio; April W. Armstrong; Alexis Ogdie; Sangyoon Shin; Alice B. Gottlieb

doi:10.3899/jrheum.211328

Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting

Jenna E. Yousif
, Joseph F. Merola
, Lourdes M. Perez-Chada
, Caterina Zagona-Prizio
, April W. Armstrong
, Alexis Ogdie
, Sangyoon Shin
, Alice B. Gottlieb

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Treatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.

Original language	English
Pages (from-to)	40-43
Number of pages	4
Journal	Journal of Rheumatology
Volume	49
Issue number	6
DOIs	https://doi.org/10.3899/jrheum.211328
State	Published - 1 Jun 2022

Keywords

GRAPPA
outcome assessment
psoriasis
psoriatic arthritis

Access to Document

10.3899/jrheum.211328

Cite this

@article{d2be420d0896466db06e07707c50fce2,

title = "Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting",

abstract = "The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Treatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.",

keywords = "GRAPPA, outcome assessment, psoriasis, psoriatic arthritis",

author = "Yousif, \{Jenna E.\} and Merola, \{Joseph F.\} and Perez-Chada, \{Lourdes M.\} and Caterina Zagona-Prizio and Armstrong, \{April W.\} and Alexis Ogdie and Sangyoon Shin and Gottlieb, \{Alice B.\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 by The Journal of Rheumatology.",

year = "2022",

month = jun,

day = "1",

doi = "10.3899/jrheum.211328",

language = "English",

volume = "49",

pages = "40--43",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "6",

}

TY - JOUR

T1 - Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting

AU - Yousif, Jenna E.

AU - Merola, Joseph F.

AU - Perez-Chada, Lourdes M.

AU - Zagona-Prizio, Caterina

AU - Armstrong, April W.

AU - Ogdie, Alexis

AU - Shin, Sangyoon

AU - Gottlieb, Alice B.

PY - 2022/6/1

Y1 - 2022/6/1

N2 - The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Treatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.

AB - The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Treatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.

KW - GRAPPA

KW - outcome assessment

KW - psoriasis

KW - psoriatic arthritis

UR - https://www.scopus.com/pages/publications/85131269985

U2 - 10.3899/jrheum.211328

DO - 10.3899/jrheum.211328

M3 - Article

C2 - 35365577

AN - SCOPUS:85131269985

SN - 0315-162X

VL - 49

SP - 40

EP - 43

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 6

ER -

Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting

Abstract

Keywords

Access to Document

Fingerprint

Cite this